Clinical Communications
COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms

https://doi.org/10.1016/j.jaip.2021.02.023Get rights and content

Cited by (0)

Conflicts of interest: M. Giannetti, C. Akin, and M. Castells receive funding from Blueprint Medicines. K. Hartmann received research funding from Euroimmun and lecture or consultancy fees from Allergopharma, ALK-Abello, Blueprint, Deciphera, Menarini, Novartis, and Takeda. The rest of the authors declare no conflicts of interest.

View Abstract